Obsurge Biotech Limited - Due diligence report

A 360° intelligence report on Obsurge Biotech: trust score, financial health, credit view, compliance, directors, growth and distress signal…

2002-01-04 Delhi, Delhi Active Unlisted Active Compliant
Share
OB Obsurge Biotech Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Obsurge Biotech — 360° Intelligence Report

Generated from MCA filings & public records
83/100
Trust Score
Low Risk

Obsurge Biotech is assessed as Low Risk with a Trust Score of 83/100. Obsurge Biotech is an active public limited indian non-government company incorporated in 2002, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Obsurge Biotech Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
60/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 1 open (25.88 Lakh) · 3 satisfied (5.02 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited2 48.0 cr
Union Bank Of India1 48.0 cr
Citibank N.A1 48.0 cr
Compliance Score: 60/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 3 court forum(s).
  • Delayed payments to MSME suppliers disclosed (50 disclosure(s)).
  • 4 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
AVIJIT CHAUHAN 01234567 Director 01/04/2018 6 yrs Approved
AMIN UL AZIZ 01234567 Director 01/04/2018 6 yrs Approved
JASWANT SINGH CHAUHAN 01234567 Director 01/04/2018 6 yrs Approved
LATISH MALHOTRA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: AVIJIT CHAUHAN (Managing Director) · LATISH MALHOTRA (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Operating for 24+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 1.71 cr.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence76/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment85/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 25.88 Lakh already registered.
  • Compliance gaps should be priced into terms.
Investor view52/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
02 Mar 2024
Charge satisfied
Hdfc Bank Limited
29 Mar 2022
Charge created
Hdfc Bank Limited - 25.88 Lakh
01 Apr 2021
Director ceased
AVIJIT CHAUHAN
31 Mar 2021
Director ceased
JASWANT SINGH CHAUHAN
30 May 2018
Charge created
Hdfc Bank Limited - 2.00 cr
31 Mar 2016
Share transfer (FY 2016)
1000.00000000 shares to JASWANT SINGH CHAUHAN HUF
30 Sep 2015
Director ceased
AMIN UL AZIZ
03 Apr 2015
Director appointed
AMIN UL AZIZ (Director)
15 Mar 2014
Charge satisfied
Citibank N.A
01 May 2013
Charge satisfied
Union Bank Of India
28 Feb 2013
Charge created
Citibank N.A - 1.50 cr
04 Dec 2009
Director ceased
SHEELAWANTI CHAUHAN
07 Jan 2008
Director appointed
AVIJIT CHAUHAN (Managing Director)
10

Key Observations

Auto-generated from the data above
4 active director(s) / partner(s); board looks stable and experienced.
4 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Pentafreight U63040MH1993PTC070564 Mumbai, Maharashtra, India
Parth Rasayan Private Limited U23201MP1999PTC013618 Jhabua, Madhya Pradesh, India
Daxin Pharmaceuticals Private Limited U24100DL2014PTC264559 New Delhi, Delhi, India
Sunrays Engineers U34300HR2005PLC137413 Manesar, Haryana, India
Aquent Polymers Private Limited U25207DL2016PTC290514 New Delhi, Delhi, India
Shubh Minerals Private Limited U13200CT2007PTC020419 Raigarh, Chattisgarh, India
Artisanspirits U15122MH2011PTC222280 Mumbai, Maharashtra, India
Psy Metal And Alloy Private Limited U28100TN2012PTC086470 Ambattur, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Obsurge Biotech before audits and certifications: compliance score 60/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Obsurge Biotech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Obsurge Biotech - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Obsurge Biotech pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Obsurge Biotech - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Obsurge Biotech an active company?

Obsurge Biotech has MCA status “Active” with a compliance score of 60/100 (Moderate).

Is Obsurge Biotech financially healthy?

Obsurge Biotech has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Obsurge Biotech?

Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Obsurge Biotech?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Obsurge Biotech have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.

Is Obsurge Biotech up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 60/100 (Moderate).

Is it risky to lend to Obsurge Biotech?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.